
Matthew Norawong is a public affairs manager at PhRMA focusing on scientific and regulatory communications. Prior to joining PhRMA, Matthew was a health policy analyst at National Journal’s Network Science Initiative where he primarily supported companies across the biopharmaceutical industry with policy analysis, partnership identification, and messaging strategy. Matthew completed his undergraduate studies in political science at the University of Washington and subsequently earned a Master of Public Health from the George Washington University. A native of the Pacific Northwest, Matthew currently resides in Washington, DC. In his personal time, Matthew enjoys playing bass guitar, competing in amateur DC sports leagues, and exploring new neighborhoods in the DMV area.
Recent Posts
Recognizing National Glaucoma Awareness Month

New Report: More than 160 medicines in development for mental illness

ICYMI: Cancer death rate continues to decline due to treatment advances

Stories from the lab: Researchers discuss innovative treatments for cancers of the blood

New Report: Nearly 800 medicines in development to treat chronic conditions

ICYMI: Patients across the country are sharing concerns about government price setting

Word of the Month: Biomarkers and surrogate endpoints

ICYMI: First pediatric patient to receive CAR-T cell therapy celebrates 10 years of being cancer-free

Ensuring timely reauthorization of PDUFA and BsUFA
